M cell-targeted DNA vaccination
AUTOR(ES)
Wu, Yunpeng
FONTE
The National Academy of Sciences
RESUMO
DNA immunization, although attractive, is poor for inducing mucosal immunity, thus limiting its protective value against most infectious agents. To surmount this shortcoming, we devised a method for mucosal transgene vaccination by using an M cell ligand to direct the DNA vaccine to mucosal inductive tissues and the respiratory epithelium. This ligand, reovirus protein σ1, when conjugated to polylysine (PL), can bind the apical surface of M cells from nasal-associated lymphoid tissues. Intranasal immunizations with protein σ1-PL-DNA complexes produced antigen-specific serum IgG and prolonged mucosal IgA, as well as enhanced cell-mediated immunity, made evident by elevated pulmonary cytotoxic T lymphocyte responses. Therefore, targeted transgene vaccination represents an approach for enabling DNA vaccination of the mucosa.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=55418Documentos Relacionados
- Rapid antibody responses by low-dose, single-step, dendritic cell-targeted immunization
- Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gamma.
- Targeted Deletion of mNth1 Reveals a Novel DNA Repair Enzyme Activity
- Targeted delivery of antigen to hamster nasal lymphoid tissue with M-cell-directed lectins.
- Selective inhibition of cell-free translation by oligonucleotides targeted to a mRNA hairpin structure.
